PRNewswire

February 2, 2026

Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites

read more →

PRNewswire

January 21, 2026

Crystalys Therapeutics Expands Leadership Team with Appointment of Justin Thacker as Chief Financial Officer to Support Advancement of Phase 3 Trials of Dotinurad

read more →

BioXconomy

January 26, 2026

Biotech firms tap new CFOs in January leadership shuffle

read more →

STAT News

January 23, 2026

Up and down the ladder: The latest comings and goings

read more →